Document Mentions (3 shared documents)

EFTA00135712

2 mentions1 same-page

Page ?Same page

l affect undersea exploration." The Times adds, "Alan E. Kohler, FBI assistant director for counterint

ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

EFTA00148896

2 mentions1 same-page

Page ?Same page

ll affect undersea exploration." The limes adds, "Alan E. Kohler, FBI assistant director for counterint

nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v

EFTA01658495

2 mentions1 same-page

Page ?Same page

ll affect undersea exploration." The Times adds, "Alan E. Kohler, FBI assistant director for counterint